Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)

India · Delayed Price · Currency is INR

137.68

-0.01 (-0.01%)

Oct 16, 2026, 3:28 PM IST

Market Cap	2.62B -19.5%
Revenue (ttm)	4.90B +21.0%
Net Income	456.11M +7.3%
EPS	22.99 +2.9%
Shares Out	19.00M
PE Ratio	5.99
Forward PE	n/a
Dividend	2.00 (1.45%)
Ex-Dividend Date	Sep 11, 2026

Volume	5,557
Open	134.40
Previous Close	137.69
Day's Range	134.40 - 141.95
52-Week Range	126.15 - 204.00
Beta	0.85
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 29, 2026

About Nath Bio-Genes (India)

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; fruit seeds, which includes Rustam +, Rustam, Mukhiya, and Ranjit; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; and seeds for vegetables comprising cabbage, French beans, chili, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, corian... [Read more]

Industry Agricultural Inputs

Sector Materials

Founded 1979

Employees 452

Stock Exchange National Stock Exchange of India

Ticker Symbol NATHBIOGEN

Full Company Profile

Financial Performance

In fiscal year 2026, Nath Bio-Genes (India)'s revenue was 4.45 billion, an increase of 21.95% compared to the previous year's 3.65 billion. Earnings were 416.30 million, an increase of 7.85%.

Financial Statements